DEFA14A: Bruker Corporation Seeks Stockholder Approval for 2026 Incentive Compensation Plan

Bruker Corporation is seeking stockholder approval for its 2026 Incentive Compensation Plan to replace the expiring 2016 plan, aiming to maintain competitive compensation practices and align employee interests with stockholders.

Summary

• Bruker Corporation is asking stockholders to approve the 2026 Incentive Compensation Plan at the Annual Stockholders Meeting on May 29, 2025.
• The 2026 Plan will replace the 2016 Incentive Compensation Plan, which expires in February 2026.
• If the 2026 Plan is not approved, Bruker will be unable to grant equity compensation to employees and directors, potentially requiring increased cash compensation.
• The company states that the 2026 Plan's cost and share pool are aligned with peer practices, with an overhang of 8.4% compared to a peer 50th percentile of 7.1%.
• The total cost (shareholder value transfer) of the 2026 Plan is estimated at 8.12%, below the ISS benchmark of 9.64%.
• Approximately 5,000,000 shares remain available for issuance under the 2016 Plan, most of which would expire if the 2026 Plan is not approved.
• Bruker's three-year average burn rate is 0.31%, below the peer 25th percentile of 0.47%.
• The 2026 Plan includes stockholder-friendly provisions such as no repricing without stockholder approval and a minimum one-year vesting requirement.
• Glass Lewis supports the 2026 Plan, while ISS recommends against it, citing excessive cost, long duration of shares, and broad discretion to accelerate vesting.
• The Bruker Board of Directors unanimously recommends that stockholders vote FOR the adoption of the 2026 Plan.

Sentiment

Score: 7

Explanation: The document presents a balanced view, highlighting both the benefits of the proposed compensation plan and the concerns raised by ISS. The company is proactively addressing potential issues and emphasizing alignment with industry standards.

Positives

• The 2026 Plan is designed to replace the expiring 2016 Plan, ensuring continued equity compensation capabilities.
• The company argues that the plan's cost and share pool are aligned with peer practices.
• The plan includes stockholder-friendly provisions, such as no repricing without stockholder approval.
• Bruker has a track record of prudently granting equity to employees, leadership, and the Board.
• The plan is supported by Glass Lewis & Co.

Negatives

• ISS recommends against the 2026 Plan, citing excessive cost, long duration of shares, and broad discretion to accelerate vesting.
• Failure to approve the plan would prevent Bruker from granting equity compensation, potentially requiring increased cash compensation.

Risks

• If the 2026 Plan is not approved, Bruker may struggle to attract and retain talent in competitive labor markets.
• The company may need to increase cash compensation to employees if equity compensation is unavailable, reducing cash resources for other business initiatives.
• The disagreement with ISS could influence stockholder voting decisions.

Future Outlook

The company aims to secure stockholder approval for the 2026 Incentive Compensation Plan to ensure continued equity compensation capabilities and maintain competitiveness in attracting and retaining talent.

Management Comments

• The Board of Directors adopted the 2026 Plan on February 18, 2025, upon the recommendation of our independent Compensation Committee, subject to stockholder approval at the 2025 Annual Meeting.
• The Company will be unable to issue equity to its employees, leadership, or Board if the 2026 Plan is not approved.
• The Bruker Board of Directors continues to unanimously recommend that our stockholders vote FOR the adoption of the 2026 Plan in Proposal 4.

Industry Context

The document highlights the importance of equity compensation in attracting and retaining talent in competitive labor markets, a common practice in the industry. The comparison to peer practices and benchmarks from proxy advisory firms like ISS and Glass Lewis indicates an awareness of industry standards and investor expectations.

Comparison to Industry Standards

• The document compares Bruker's overhang to the peer 2023 overhang 50th percentile (7.1%).
• The total cost (shareholder value transfer) of the 2026 Plan is compared to the Institutional Shareholder Services (ISS) benchmark of 9.64%.
• Bruker's three-year average burn rate of 0.31% is compared to the peer 25th percentile (0.47%).
• The document mentions that only 12% of companies in the Russell 3000 limit their boards' ability to accelerate vesting to only death or disability.

Stakeholder Impact

• Approval of the 2026 Plan is intended to benefit employees and directors by providing equity compensation.
• Stockholders are impacted by the potential dilution from the share pool and the overall cost of the plan.
• Failure to approve the plan could negatively impact employee morale and retention, potentially affecting the company's performance.

Next Steps

• Stockholders are encouraged to read the proxy statement and supplementary information.
• Stockholders are encouraged to submit their proxy or voting instructions as soon as possible.
• Stockholders will vote on Proposal 4 at the Annual Stockholders Meeting on May 29, 2025.

Key Dates

Keywords

Incentive Compensation Plan, Equity Compensation, Stockholder Approval, Bruker Corporation, 2026 Plan, 2016 Plan, Compensation, Proxy Statement